Search

Harvey E. Behrend

Examiner (ID: 7425)

Most Active Art Unit
2201
Art Unit(s)
2201, 3641, 2204, 2506, 2899
Total Applications
899
Issued Applications
629
Pending Applications
35
Abandoned Applications
235

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6735998 [patent_doc_number] => 20030013633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'USE OF MOLECULES THAT MODULATE AN ENERGY RELATED ASSOCIATED STATE' [patent_app_type] => new [patent_app_number] => 09/327199 [patent_app_country] => US [patent_app_date] => 1999-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9067 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013633.pdf [firstpage_image] =>[orig_patent_app_number] => 09327199 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/327199
USE OF MOLECULES THAT MODULATE AN ENERGY RELATED ASSOCIATED STATE Jun 6, 1999 Abandoned
Array ( [id] => 4261564 [patent_doc_number] => 06258846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Nutritional supplements' [patent_app_type] => 1 [patent_app_number] => 9/323159 [patent_app_country] => US [patent_app_date] => 1999-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9735 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258846.pdf [firstpage_image] =>[orig_patent_app_number] => 323159 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/323159
Nutritional supplements May 31, 1999 Issued
09/321456 METHODS OF PROMOTING OR ENHANCING INTERLEUKIN-12 PRODUCTION THROUGH ADMINISTRATION OF THALIDOMIDE May 26, 1999 Abandoned
Array ( [id] => 4323380 [patent_doc_number] => 06331560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Tumor necrosis factor alpha (TNF-.alpha.) inhibiting pharmaceuticals' [patent_app_type] => 1 [patent_app_number] => 9/318774 [patent_app_country] => US [patent_app_date] => 1999-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7520 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331560.pdf [firstpage_image] =>[orig_patent_app_number] => 318774 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/318774
Tumor necrosis factor alpha (TNF-.alpha.) inhibiting pharmaceuticals May 25, 1999 Issued
Array ( [id] => 1508111 [patent_doc_number] => 06441027 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Method of regulating the female reproductive system through angiogenesis inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/313528 [patent_app_country] => US [patent_app_date] => 1999-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 9 [patent_no_of_words] => 11674 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/441/06441027.pdf [firstpage_image] =>[orig_patent_app_number] => 09313528 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/313528
Method of regulating the female reproductive system through angiogenesis inhibitors May 16, 1999 Issued
09/312168 METHOD AND COMPOSITION FOR TREATING MAMMALIAN NASAL AND SINUS DISEASES CAUSED BY INFLAMMATORY RESPONSE May 13, 1999 Abandoned
Array ( [id] => 6892254 [patent_doc_number] => 20010018416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING HEPATITIS-C' [patent_app_type] => new [patent_app_number] => 09/311497 [patent_app_country] => US [patent_app_date] => 1999-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4431 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018416.pdf [firstpage_image] =>[orig_patent_app_number] => 09311497 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/311497
Compositions and methods for treating hepatitis-C May 12, 1999 Issued
Array ( [id] => 1521089 [patent_doc_number] => 06413970 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Pharmaceutical composition for treating viral diseases' [patent_app_type] => B1 [patent_app_number] => 09/254548 [patent_app_country] => US [patent_app_date] => 1999-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 3777 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413970.pdf [firstpage_image] =>[orig_patent_app_number] => 09254548 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/254548
Pharmaceutical composition for treating viral diseases Apr 20, 1999 Issued
Array ( [id] => 6033755 [patent_doc_number] => 20020019439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'THERAPEUTIC QUASSINOID PREPARATIONS WITH ANTINEOPLASTIC, ANTIVIRAL, AND HERBISTATIC ACTIVITY' [patent_app_type] => new [patent_app_number] => 09/293606 [patent_app_country] => US [patent_app_date] => 1999-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9782 [patent_no_of_claims] => 120 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019439.pdf [firstpage_image] =>[orig_patent_app_number] => 09293606 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/293606
Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity Apr 15, 1999 Issued
09/281893 VIRAL TREATMENT Mar 30, 1999 Abandoned
09/283356 NOVEL FORMULATIONS COMPRISING LIPID-REGULATING AGENTS Mar 30, 1999 Abandoned
09/281895 METHOD OF PREVENTING VIRAL INFECTIONS Mar 30, 1999 Abandoned
09/281115 METHODS AND COMPOSITIONS FOR TREATING ALLERGIC AND RELATED DISORDERS USING FLUORINATED DESCARBOETHOXYLORATADINE Mar 28, 1999 Abandoned
Array ( [id] => 4329445 [patent_doc_number] => 06319951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections' [patent_app_type] => 1 [patent_app_number] => 9/117890 [patent_app_country] => US [patent_app_date] => 1999-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5084 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319951.pdf [firstpage_image] =>[orig_patent_app_number] => 117890 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/117890
Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections Mar 22, 1999 Issued
Array ( [id] => 4155600 [patent_doc_number] => 06107303 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Treatment of Epstein Barr infection' [patent_app_type] => 1 [patent_app_number] => 9/268889 [patent_app_country] => US [patent_app_date] => 1999-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3435 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107303.pdf [firstpage_image] =>[orig_patent_app_number] => 268889 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/268889
Treatment of Epstein Barr infection Mar 14, 1999 Issued
09/254701 COMPOSITION COMPRISING AN ANTIVIRAL OR ANTIBACTERIAL AGENT FOR PREVENTING TRANSMISSION OF DISEASES Mar 10, 1999 Abandoned
Array ( [id] => 7636456 [patent_doc_number] => 06380201 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists' [patent_app_type] => B1 [patent_app_number] => 09/262726 [patent_app_country] => US [patent_app_date] => 1999-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65452 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380201.pdf [firstpage_image] =>[orig_patent_app_number] => 09262726 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/262726
Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists Mar 3, 1999 Issued
Array ( [id] => 1420242 [patent_doc_number] => 06514979 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor' [patent_app_type] => B1 [patent_app_number] => 09/261712 [patent_app_country] => US [patent_app_date] => 1999-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10063 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514979.pdf [firstpage_image] =>[orig_patent_app_number] => 09261712 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/261712
Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor Mar 2, 1999 Issued
Array ( [id] => 4352584 [patent_doc_number] => 06291446 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Therapeutic treatment for cytomegalovirus infection' [patent_app_type] => 1 [patent_app_number] => 9/253700 [patent_app_country] => US [patent_app_date] => 1999-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5124 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291446.pdf [firstpage_image] =>[orig_patent_app_number] => 253700 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/253700
Therapeutic treatment for cytomegalovirus infection Feb 21, 1999 Issued
09/242614 VITAMINE PREPARATIONS FOR REDUCING OXYGEN CONSUMPTION DURING PHYSICAL EFFORTS Feb 18, 1999 Abandoned
Menu